BridgeBio Pharma, Inc. (BBIO) Options Statistics & Positioning

BridgeBio Pharma, Inc. (BBIO) options trade at a 30-day at-the-money implied volatility of 34.4%, an IV rank of 18 out of 100 over the past year. The options market prices a ±$4.07 (±4.8%) move in BBIO for the front expiration. Max pain sits at $67.5 and the put/call open interest ratio is 0.62. Statistics are computed by OptiView from delayed OPRA options data and refresh every trading day.

Data as of Jul 10, 2026, 8:00 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.

Last close

$85.44

52-week range

$44.69 – $90.51

ATM IV (30d)

34.4%

IV rank

18 / 100

Low

Expected move

±$4.07 (±4.8%)

Put/call OI

0.62

Call-heavy

Max pain

$67.5

↓ 21.0% below close

Next earnings

Aug 4, 2026

Most Active BBIO Contracts

Contract	Expiration	DTE	Last	IV	Volume
BBIO $87.5 call	Jul 17, 2026	7d	$1.10	36.3%	364
BBIO $75 call	Jul 17, 2026	7d	$11.50	0.0%	332
BBIO $75 call	Sep 18, 2026	70d	$14.75	50.1%	300
BBIO $75 put	Sep 18, 2026	70d	$3.00	49.3%	300
BBIO $85 put	Jul 17, 2026	7d	$1.87	32.5%	263

See all active BBIO contracts →

Explore BBIO Options Statistics

BBIO Implied Volatility

34.4% ATM IV (30d)

An IV rank of 18 places implied volatility in the lower part of its 52-week range.

Full implied volatility analysis →

BBIO Open Interest

0.62 put/call OI ratio

41,250 calls and 25,447 puts outstanding across all expirations.

Full open interest analysis →

BBIO Max Pain

$67.5 max pain

21.0% below the last close — see how max pain has moved over the past year.

Full max pain analysis →

BBIO Gamma Exposure

$366.38M net GEX

Positive dealer gamma — hedging currently leans against price swings.

Full gamma exposure analysis →

BBIO Options Volume

2,838 contracts traded

Put/call volume ratio 0.38 — plus contracts running far above their usual volume.

Full volume & flow analysis →

BBIO Most Active Options

$75 top volume strike

The 25 most actively traded BBIO contracts with price, IV, greeks, and volume vs. average.

Full active contracts analysis →

Upcoming Earnings

BBIO's next expected earnings date is Aug 4, 2026. Options currently price a ±$4.07 (±4.8%) move for the front expiration.

Explore the payoff profile of option on BBIO for free

Build multi-leg BBIO strategies, visualize payoffs, and scan the full US options universe with OptiView.

Open BBIO in the platform Scan options

BBIO Options FAQ

When is BBIO's next earnings date?

BBIO's next expected earnings date is Aug 4, 2026. Options currently price a ±$4.07 (±4.8%) move for the front expiration.

How often is BBIO options data on this page updated?

All BBIO statistics on this page are computed by OptiView from delayed OPRA options data and refresh every trading day after the session close.

Where can I see BBIO max pain, open interest, and implied volatility in detail?

OptiView publishes dedicated BBIO pages for implied volatility, max pain, open interest, gamma exposure, options volume, and the most active contracts — each with charts, history, and a plain-English explanation of what the numbers mean.

Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.

Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.